PST3.1a - CAS 1096144-06-7

PST3.1a is a selective inhibitor of Mannoside acetyl glucosaminyltransferase 5 (MGAT5), used for studying glioblastoma multiforme (GBM) . PST3.1a inhibits TGF-βR and FAK signalling associated with doublecortin (DCX), increases OLIG2 expression, and suppresses the invasion and proliferation of GBM initiator cells (GICs) .

FAK, Others, TGF-beta/Smad, Transferase, Acyltransferase

Cytoskeletal Signaling, Angiogenesis, Tyrosine Kinase/Adaptors, Others, Metabolism, Stem Cells

1096144-06-7

0.9812

C32H33O6P

544.57

O[C@@H]([P@@](O[C@@H]1COCC2=CC=CC=C2)(C3=CC=CC=C3)=O)[C@@H](OCC4=CC=CC=C4)[C@@H]1OCC5=CC=CC=C5

-20°C

Ice Packs

Small Compound